PUBLISHER: The Business Research Company | PRODUCT CODE: 1939275
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939275
Artificial organs and bionics encompass machines or devices designed to substitute the functions of a deficient or absent human organ, while bionics involves constructing artificial systems mirroring certain characteristics of living organisms. Their primary objective is to enhance an individual's lifespan and functionality.
Within this domain, the main products include artificial organs and artificial bionics. Artificial organs are devices utilized to replicate the functions of missing or impaired human organs or body parts. These can be categorized based on fixation types as either implantable or externally-worn, and further segmented into cardiac bionics and brain bionics. The technologies encompassed within this field encompass mechanical bionics and electronic bionics.
Tariffs are impacting the artificial organ and bionics market by increasing costs of imported electronic components, sensors, actuators, biocompatible materials, and precision manufacturing equipment. Healthcare systems in North America and Europe are most affected due to dependence on advanced imported components, while Asia-Pacific faces export-related cost pressures. These tariffs are raising device prices and extending development timelines. At the same time, they are encouraging domestic innovation, localized production capabilities, and strategic investments in next-generation artificial organ technologies.
The artificial organ and bionics market research report is one of a series of new reports from The Business Research Company that provides artificial organ and bionics market statistics, including artificial organ and bionics industry global market size, regional shares, competitors with a artificial organ and bionics market share, detailed artificial organ and bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ and bionics industry. This artificial organ and bionics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial organ and bionics market size has grown rapidly in recent years. It will grow from $35.86 billion in 2025 to $40.03 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising organ transplant shortages, advancements in biomedical engineering, expansion of prosthetics adoption, increasing survival rates of chronic disease patients, improvements in surgical implantation techniques.
The artificial organ and bionics market size is expected to see rapid growth in the next few years. It will grow to $63.1 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing investments in biohybrid organ research, rising demand for intelligent bionic systems, expansion of brain-computer interface applications, growing focus on quality-of-life enhancement, technological convergence in organ replacement therapies. Major trends in the forecast period include increasing development of advanced artificial organs, rising adoption of bionic limbs and exoskeletons, growing integration of neural interface technologies, expansion of implantable life-support devices, enhanced focus on long-term organ replacement solutions.
The rising number of transplants is expected to drive the growth of the artificial organ and bionics market in the coming years. Transplantation refers to a surgical procedure in humans or animals in which an organ or tissue is transferred from a donor to a recipient, or from one part of the body to another. Artificial organs are devices implanted in the body to replace a damaged organ and perform specific functions of the natural organ, enabling patients to maintain a quality of life similar to normal conditions. For example, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific and educational organization, the United States recorded 48,149 organ transplants in 2024, exceeding 48,000 and representing a 3.3% increase compared to 2023. Of these procedures, 41,119 transplants were from deceased donors, while 7,030 were from living donors. Therefore, the increasing number of transplants is driving the growth of the artificial organ and bionics market.
Major companies active in the artificial organs and bionics market are prioritizing advanced technological innovations, including microprocessor-controlled prosthetic knees, to improve mobility and enable more natural, intuitive movement for individuals with lower-limb amputations. These prosthetic knees use integrated sensors and onboard processors to continuously adjust to a user's walking pattern in real time. For example, in January 2025, BionicM, a Japan-based startup and spin-off from the University of Tokyo specializing in robotics and prosthetics, introduced its Bio Leg in the U.S. market. This powered knee, named a CES 2025 Best of Innovation award winner, uses robotic technology to compensate for lost muscle function, delivering smoother motion, greater safety, and an improved quality of life for amputees.
In November 2024, OrganOx Ltd, a UK-based organ technology company focused on normothermic perfusion systems for donor organs, entered into a partnership with eGenesis to clinically co-develop an organ support therapy. This initiative combines OrganOx's perfusion platform with genetically engineered porcine livers to address acute liver failure. Through this collaboration, OrganOx seeks to strengthen its position in the artificial organ and bionics market by enabling a novel biologically engineered liver support solution that can enhance patient outcomes and broaden access to organ replacement therapies.
Major companies operating in the artificial organ and bionics market are Abiomed Inc., Asahi Kasei Medical Co. Ltd, Baxter, Berlin Heart GmbH, Cyberonics Inc., Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, Bornlife Prosthetic and Orthotic Inc., Nano Retina Ltd, Edwards Lifesciences Corporation, Sonova, Cochlear Limited, Advanced Bionics AG, Ottobock SE & Co. KGaA, Second Sight Medical Products Inc., iWalk Inc., Jarvik Heart Inc., St. Jude Medical Inc., Harmonic Bionics Inc., Open Bionics, Beta Bionics Inc., Bionic Prosthetics and Orthotics, Mobius Bionics, Touch Bionics Ltd
North America was the largest region in the artificial organ and bionics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global artificial organ and bionics market report during the forecast period. The regions covered in the artificial organ and bionics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial organ and bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial organs and bionics market consists of sales of artificial hearts, total artificial hearts (TAH), artificial kidneys, artificial livers, ear bionics, vision bionics, orthopaedic bionics, and heart bionics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Organ And Bionics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial organ and bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial organ and bionics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial organ and bionics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.